Enantioselective Rhodium-Catalyzed Addition of Arylboronic Acids to Trifluoromethyl Ketones
[3] For reviews, see: a) T. Billard, B. R. Langlois, Eur. J.
stituted tertiary alcohols in high yields and excellent
enantioselectivities. The new chiral bisphosphorus
ligand 4 with a deep chiral pocket is the key to the
success of this transformation. Applications of this
methodology for syntheses of biologically active mol-
ecules and further improvement of the current cata-
lyst system are currently under investigation and
progress will be reported in due course.
Org. Chem. 2007, 891; b) J.-A. Ma, D. Cahard, Chem.
Rev. 2008, 108, PR1; c) N. Shibata, S. Mizuta, H.
Kawai, Tetrahedron: Asymmetry 2008, 19, 2633. For
recent papers, see: d) H. Kawai, T. Kitayama, E. Toku-
naga, N. Shibata, Eur. J. Org. Chem. 2011, 5959; e) H.
Kawai, K. Tachi, E. Tokunaga, M. Shiro, N. Shibata,
Org. Lett. 2010, 12, 5104; f) H. Nagao, Y. Yamane, T.
Mukaiyama, Chem. Lett. 2007, 36, 666; g) H. Nagao, Y.
Kawano, T. Mukaiyama, Bull. Chem. Soc. Jpn. 2007,
80, 2406; h) S. Mizuta, N. Shibata, S. Akiti, H. Fujimo-
to, S. Nakamura, T. Toru, Org. Lett. 2007, 9, 3707; i) H.
Kawai, K. Tachi, E. Tokunaga, M. Shiro, N. Shibata,
Org. Lett. 2010, 12, 5104.
Experimental Section
General Procedure
[4] For a recent review, see: J. Nie, H.-C. Guo, D. Cahard,
To a mixture of trifluoromethyl ketone 5 or 8 (0.25 mmol,
1 equiv.), arylboronic acid 6 or 9 (76 mg, 0.5 mmol, 2 equiv.),
K2CO3 (100 mg, 0.75 mmol, 3 equiv.), ligand 4 (5.9 mg,
J.-A. Ma, Chem. Rev. 2011, 111, 455.
[5] a) G.-W. Zhang, W. Meng, H. Ma, J. Nie, W.-Q. Zhang,
J.-A. Ma, Angew. Chem. 2011, 123, 3600; Angew.
Chem. Int. Ed. 2011, 50, 3538; b) N. Chinkov, A. Warm,
E. M. Carreira, Angew. Chem. 2011, 123, 3014; Angew.
Chem. Int. Ed. 2011, 50, 2957; c) R. Motoki, M. Kanai,
M. Shibasaki, Org. Lett. 2007, 9, 2997; d) C. Lauzon,
A. B. Charette, Org. Lett. 2006, 8, 2743; e) R. Motoki,
D. Tomita, M. Kanai, M. Shibasaki, Tetrahedron Lett.
2006, 47, 8083; f) B. Jiang, Y. Feng, Tetrahedron Lett.
2002, 43, 2975; g) L.-S. Tan, C.-Y. Chen, R. D. Tillyer,
E. J. J. Grabowski, P. J. Reider, Angew. Chem. 1999,
111, 724; Angew. Chem. Int. Ed. 1999, 38, 711.
0.009 mmol, 3.6 mol%) and [RhACHTNUGTRNE(UNG C2H4)2Cl]2 (1.5 mg,
0.00375 mmol, 1.5 mol%) was added MTBE (1.5 mL). The
mixture was stirred at 608C for 20 h and then concentrated.
The residue was directly subjected to silica gel column chro-
matography [dichloromethane/hexanes (7:3 v/v) as the
eluent] to afford the desired alcohol product 7 or 10. The
enantioselectivity was determined by chiral HPLC on a Chir-
alcel OD-H, Chiralcel AD-H, or Lux Amylose-2 column.
[6] K. Yearick, C. Wolf, Org. Lett. 2008, 10, 3915.
[7] a) S. L. X. Martina, R. B. C. Jagt, J. G. de Vries, B. L.
Feringa, A. J. Minnaard, Chem. Commun. 2006, 4093;
b) V. R. Jumde, S. Facchetti, A. Iuliano, Tetrahedron:
Asymmetry 2010, 21, 2775.
[8] a) N. Hara, R. Tamura, Y. Funahashi, S. Nakamura,
Org. Lett. 2011, 13, 1662; b) X.-J. Wang, Y. Zhao, J.-T.
Liu, Org. Lett. 2007, 9, 1343; c) D.-H. Zhang, C. Y.
Yuan, Tetrahedron 2008, 64, 2480.
Acknowledgements
We are grateful to NSFC (21272254), the “Thousand Plan”
Youth program, the Innovation Fund of State Key Laborato-
ry of Bioorganic and Natural Products Chemistry, and gener-
ous support from Boehringer Ingelheim.
[9] a) C. Palacio, S. J. Connon, Org. Lett. 2011, 13, 1298;
b) M. Bandini, R. Sinisi, A. Umani-Ronchi, Chem.
Commun. 2008, 4360; c) F. Tur, J. M. Saꢃ, Org. Lett.
2007, 9, 5079.
References
[1] For reviews, see: a) E. N. Jacobsen, A. Pfaltz, H. Yama-
moto, (Eds.), Comprehensive Asymmetric Catalysis,
Vols. 1–3, Springer, Berlin, 1999; b) L. Pu, H.-B. Yu,
Chem. Rev. 2001, 101, 757; c) K. Fagnou, K. M. Laut-
ens, Chem. Rev. 2003, 103, 169; d) S. E. Denmark, J.
Fu, Chem. Rev. 2003, 103, 2763; e) C. Garcia, V. S.
Martin, Curr. Org. Chem. 2006, 10, 1849; f) O. Riant, J.
Hannedouche, Org. Biomol. Chem. 2007, 5, 873; g) P.
Tian, H.-Q. Dong, G.-Q. Lin, ACS Catal. 2012, 2, 95.
[2] a) D. L. Romero, Ann. Rep. Med. Chem. 1994, 29, 123;
b) E. De Clercq, Rev. Med. Virol. 2009, 19, 287; c) Z.-
K. Wan, E. Chenail, H.-Q. Li, C. Kendall, Y. Wang, S.
Gingras, J. Xiang, W. W. Massefski, T. S. Mansour, E.
Saiah, J. Org. Chem. 2011, 76, 7048; d) L. D. Julian, Z.
Wang, T. Bostick, S. Caille, R. Choi, M. DeGraffenreid,
Y. Di, X. He, R. W. Hungate, J. C. Jaen, J. Liu, M.
Monshouwer, D. McMinn, Y. Rew, A. Sudom, D. Sun,
H. Tu, S. Ursu, N. Walker, X. Yan, Q. Ye, J. P. Powers,
J. Med. Chem. 2008, 51, 3953; e) D. J. Kopecky, X. Y.
Jiao, B. Fisher, S. McKendry, M. Labelle, D. E. Piper, P.
Coward, A. K. Shiau, P. Escaron, J. Danao, A. Chai, J.
Jaen, F. Kayser, Bioorg. Med. Chem. Lett. 2012, 22,
2407.
[10] a) K. Mikami, K. Aikawa, S. Kainuma, Y. Kawakami,
T. Saito, N. Sayo, H. Kumobayashi, Tetrahedron: Asym-
metry 2004, 15, 3885; b) K. Aikawa, S. Kainuma, M.
Hatano, K. Mikami, Tetrahedron Lett. 2004, 45, 183;
c) K. Mikami, H. Kakuno, K. Aikawa, Angew. Chem.
2005, 117, 7423; Angew. Chem. Int. Ed. 2005, 44, 7257;
d) S. Doherty, J. G. Knight, C. H. Smyth, R. W. Har-
rington, W. Clegg, Organometallics 2007, 26, 5961.
[11] a) N. Gathergood, W. Zhuang, K. A. Jørgensen, J. Am.
Chem. Soc. 2000, 122, 12517; b) W. Zhuang, N. Gather-
good, R. G. Hazell, K. A. Jørgensen, J. Org. Chem.
2001, 66, 1009.
[12] X.-N. Wang, P.-L. Shao, H. Lv, S. Ye, Org. Lett. 2009,
11, 4029.
[13] M. Sakai, M. Ueda, N. Miyaura, Angew. Chem. 1998,
110, 3475; Angew. Chem. Int. Ed. 1998, 37, 3279.
[14] a) R. B. C. Jagt, P. Y. Toullec, J. G. de Vries, B. L. Ferin-
ga, A. J. Minnaard, Org. Biomol. Chem. 2006, 4, 773;
b) H.-F. Duan, J.-H. Xie, W.-J. Shi, Q. Zhang, Q.-L.
Zhou, Org. Lett. 2006, 8, 1479; c) T. Nishimura, H. Ku-
mamoto, M. Nagaosa, T. Hayashi, Chem. Commun.
Adv. Synth. Catal. 2013, 355, 1297 – 1302
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1301